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Autophagy is a self-degrading process that is triggered by diverse stimuli including ionizing radia-
tion. In this study we show novel phenomena in which transfection of miR-199a-5p mimic signiﬁ-
cantly suppresses IR-induced autophagy in MCF7 cells, and up-regulates basal and IR-induced
autophagy in MDA-MB-231 breast cancer cells. We also identify DRAM1 and Beclin1 as novel target
genes for miR-199a-5p. Overexpression of miR-199a-5p inhibits DRAM1 and Beclin1 expression in
MCF7 cells, while it enhances expression of these genes in MDA-MB-231 cells. Furthermore, we show
that miR-199a-5p sensitizes MDA-MB-231 cells to irradiation. Therefore, our data identify miR-199a-
5p as a novel and unique regulator of autophagy, which plays an important role in cancer biology
and cancer therapy.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Autophagy is an evolutionarily conserved intracellular catabolic
process in which a cell degrades long-lived proteins and damaged
organelles, such as the endoplasmic reticulum, Golgi apparatus,
and mitochondria [1]. Autophagy is active at basal cellular growth
levels to function as endogenous cleaning system, and also can be
triggered by diverse stressful conditions, such as adaptation to
starvation, oxidative or genotoxic stress, and elimination of patho-
gens [2,3]. And thus, deregulated autophagy has been linked to
pathologic conditions such neurodegenerative diseases, cardiomy-
opathy, and cancer [4]. The exact role of autophagy in carcinogen-
esis is still elusive. Autophagy can behave as a tumor suppressor or
oncogene. The similar paradox is exhibited during tumor therapy,
in which autophagy could play pro-survival role and deteriorate
the cancer therapeutic outcome or autophagy could work as pro-
grammed cell death to ameliorate the over all anti-tumor efﬁcacy
[5]. Therefore, achieving better molecular understanding of
autophagy and the discovery of speciﬁc autophagy modulators
suitable for in vivo use will help to dramatically improve cancer
therapy [6]. MicroRNAs (miRNAs), the short (22 nucleotides)non-coding RNAs, have emerged recently as novel endogenous
gene regulators. They bind by incomplimentary base pairing to
the 30-untranslated region (30UTR) of their target mRNA to post-
transcriptionally suppress gene expression [7]. MiRNAs have been
shown to play important roles in virtually all fundamental cellular
events like cell proliferation and apoptosis [8,9]. MiRNAs were
found to be deregulated in various body tumors and affect crucial
signaling networks which control carcinogenesis. And hence miR-
NAs are being categorized as tumor suppressors and oncogenes
[10]. MiR-17–92 cluster has been found to be overexpressed and
possesses oncogenic potential in human B cell lymphoma [11],
lung [12] and colorectal cancer [13]. MiR-let-7 expression was
found to be lower in lung tumors than in normal lung tissue, and
replacement of miR-let-7 suppressed lung cancer growth via tar-
geting the RAS proto-oncogene [14]. Until very recently, accumu-
lating studies showed that miRNAs are novel autophagy
modulators in human cancer cells [15]. MiRNA-30a and miRNA-
376b have been demonstrated to target and inhibit Beclin1 and
thereby blocking autophagy in cancer cells [16,17]. MiR-199a-5p
has been reported to deregulated in several aggressive tumor types
[18–22], suggesting that this miRNA could have distinct patho-
physiological functions. Down-regulation of miR-199a-5p was ob-
served in hepatocellular [23], breast and testicular cancers [24,25].
Moreover, recent studies indicated that miR-199a-5p is a putative
tumor suppressor in human liver and testicular cancer cells
[23,25]. Despite all these studies, functions and the target genes
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and need to be discovered. Due to the importance of autophagy
in cancer biology and therapeutics, we were interested to explore
the impact of miR-199a-5p on the process of autophagy and iden-
tify the related target genes in human breast cancer cells.2. Materials and methods
2.1. Cell lines and treatment
Human breast cancer cell lines, MCF7 and MDA-MB-231 were
cultured at 37 C in Dulbecco’s Modiﬁed Eagle Medium (GIBCO)
supplemented with 10% fetal bovine serum, 100 units/ml penicil-
lin and 100 lg/ml streptomycin in a humid incubator with 5%
CO2. Cells were transfected with 100 nM of miR-199a-5p mimic
or Negative Control (NC) (GenePharma, Shanghai, China) using
lipofectamine™ 2000 (Invitrogen) followed by IR. NC has a un-
ique sequence designed such that it does not target any human
genes. (Mimic and NC sequences are listed in Supplementary
Table S1).
2.2. Radiation
180-KVp X-ray generator (Model XSZ-Z20/20, Dandong, liaon-
ing, China) was utilized to deliver radiation at a dose rate of
0.41 Gy/min (200 kV; 18 mA).
2.3. RNA extraction
Total RNA was extracted 48 h after transfection with mimic or
NC, using TRIzol reagent (Invitrogen) according to the manufac-
turer’s protocol. Samples were stored at 80 C before use.
2.4. Quantitative real-time (qRT)-PCR detection of miR-199a-5p
miRCURY LNA™ Universal RT microRNA PCR (Exiqon) was used
for detection of miRNA expression by quantitative real-time PCR
on the Stratagene MX3000p thermocycler according to the manu-
facture’s protocol. 20 ng of RNA was used for reverse transcription
and the reverse transcription mixture was incubated at 42 C for
60 min followed by heat-inactivation of the reverse transcriptase
for 5 min at 95 C. cDNA template was diluted 80-fold in nuclease
free water. Melt curve was made to determine the optimal condi-
tion. The PCR protocol is as follows: denaturation 95 C for 10 min,
then 40 ampliﬁcation cycles (95 C for 10 s and 60 C for 1 min, at a
ramp-rate of 1.6 C/s). U6 sequence was used as a normalization
control for all samples.2.5. Bioinformatics predict for target gene of miR-199a-5p
MiRNA target genes were predicted by union of miRBase Target
v4 (http://www.mirbase.org/), PicTar 4.0 (http://pictar.mdc-ber-
lin.de/) and TargetScan (http://www.targetscan.org/), followed by
screening for availability of gene symbols in NCBI human se-
quences (http://www.ncbi.nlm.nih.gov/).
2.6. Plasmid construction
The 30-untranslated region (30UTR) of DRAM1 (GenBank ID:
NM_018370.2, region from 2572 to 3543 bp) and BECN1 (Gen-
bank ID: NM_003766, region from 1531 to 2145 bp) carrying
putative miR-199a-5p binding site were ampliﬁed by PCR from
human genomic DNA of healthy blood donor. DRAM1–30UTR
was then cloned in XbaI sites of pGL3-control vector (Promega),
and BECN1–30UTR was cloned in between SacI and MluI sites ofpMIR-REPORT™ luciferase vector (Ambion). PCR with appropriate
primers also generated inserts with mutated miR-199a-5p com-
plementary sites. All PCR products cloned into the plasmid were
veriﬁed by DNA sequencing to ensure that they were free of
mutations and in the correct cloning direction. (Primer se-
quences are listed in Supplementary Table S1.)2.7. Luciferase reporter assays
MCF7 cells and MDA-MB-231cells were cultured in 24-well
plates (0.5  105/well). Each transfected with 30 ng of pMIR-BECN1
3’UTR or 200 ng of PGL3-DRAM1 30UTR, together with 5 ng
pRL-SV40 vector (Promega), which contains the Renilla luciferase
gene, used to normalize transfection efﬁciency, and 100 nM of
miR-199a-5pmimic or Negative control (NC) (GenePharma). Trans-
fection was done using Lipofectamine™ 2000 (Invitrogen). At 36 h
or 48 h after transfection, ﬁreﬂy and Renilla luciferase activities
were examined using the Dual-Luciferase Reporter Assay
(Promega). Each transfection was repeated in Quintuplicate. The
experiment was done thrice independently.2.8. Western blot analysis
MCF7 Cells were harvested at 20 h after irradiation and MDA-
MB-231 cells were harvested at 16 h after irradiation (based on
the time-course curve). Cell pellets were lysed in RIPA lysis buf-
fer. 30 or 60 lg of total protein was separated by SDS–PAGE,
transferred to nitrocellulose membrane, and analyzed by immu-
noblotting using the chemiluminescence (Santa Cruz). The pri-
mary antibodies used were DRAM1 (1:300) (Abcam) and LC3-I/
II (1:300) (Cell Signaling), GAPDH (1:1000) and BECN1 (1:1000)
(Santa Cruz). The autophagic ﬂux was analysised by Western
blot to detect MAPLC3 expression of breast cancer cells treated
with 20 lM chloroquine (CQ) (Sigma). The intensity of protein
bands were quantiﬁed using image j software and the ratio of
speciﬁc band to control was analyzed.
2.9. GFP-LC3 localization assay
In order to generate stable expression of GFP-LC3 in MCF7 cells,
we transiently co-transfected pQN-GFP-LC3 vector (10 lg) and
Amphopack (10 lg) plasmid into packaging cell line of 293T. The
pseudoviral particles were puriﬁed 72 h post-transfection and
mixed with polybrene (8 lg/ml), the mixtures were used to infect
MCF7 cells. 1000 lg/ml G418 was used for selection until positive
colonies acquired. MCF7 cells stably expressing GFP-LC3 were
planted at a density of (1  105) in 6-well plate with glass cover-
slips and exposed to the indicated transfections of microRNA and
IR. Cells were then stained by methanol for 10 min. GFP-LC3 punc-
ta were visualized under an inverted ﬂuorescence (Olympus XSZ-
D2) microscope equipped with CCD cameras and stack of images
were captured and analyzed for presence of more than ﬁve puncta
per cell.
2.10. Cell viability assay
Cells were seeded at a density of 4  103 in 96-well plates.
24 h after the transtection of miRNAs (100 nM) cells were trea-
ted with IR. 72 h later, 100 ll Cell Counting Kit-8 (CCK8) (Dojin-
do, Beijing, China) solution were added to each well and the
plates were incubated at 37 C for 4 h. Absorbance at 560 nm
was measured using a microplate spectrophotometer (BioTek™).
Absorbance of cell survival was calculated relative to control
cells, which were set to 100%. Each transfection was repeated
in Quintuplicate.
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For cell cycle detection, cells were plated into 6-well plates
(2  105/well) and treated with miRNAs 48 h or combined with
IR treatment. Cells were washed with PBS and stained in the dark
with 50 lg/ml phosphatidyl inositol (PI) and 0.1% ribonuclease A
(RNase A) in 400 ll of PBS for 15 min, cells were then analyzed
by using FACSort Flow Cytometer (Becton Dickinson).2.12. Statistical analysis
Statistical evaluations are presented as mean ± S.E. Data were
analyzed using the Student’s t-test or v2 test for statistical signiﬁ-
cance. P values were considered signiﬁcant if P < 0.05.3. Results
3.1. Overexpression of miR-199a-5p inhibits radiation-induced
autophagy in MCF7 cell line
Synthetic miR-199a-5p (mimic) was added to MCF7 cells and
quantitative real time-PCR (qRT-PCR) was performed to ensure suc-
cessful overexpression of miRNA. As shown in (Fig. 1A),
miR-199a-5p level was enhanced to more than 20 folds after trans-
fection of MCF7 cells with mimic relative to NC transfected cells.
During autophagy process, the mammalian ATG8-homologue
(LC3-I) is processed and recruited to the autophagosomes, where
the lipdated (LC3-II) is generated [26]. To examine the effect ofFig. 1. Overexpression MiR-199a-5p suppresses IR-induced autophagy in MCF7 cells. (A)
to detect the miR-199a-5p level. (B) Representative images of MCF7 cells stably expr
distributes evenly (autophagy was not induced), right: white arrow pointing at typical pu
expression of GFP-LC3 were transfected with miR-199a-5p mimic (100 nM) or NC (100 n
induced autophagy). The error bars indicate the standard error of the mean (S.E.M.) for
expression in MCF7 cells after transfection with or without irradiation. (E) After transfect
then MAPLC3 was detected by Western blot.miR-199a-5p on autophagy, we stably transfected MCF7 cells with
GFP-LC3 plasmid to monitor autophagosome formation through di-
rect ﬂuorescencemicroscopy,measured as an increase in puncta po-
sitive cells (Fig. 1B). To trigger autophagy,weused ionizing radiation
(IR) which has been shown to induce autophagy effectively in di-
verse tumor cells including breast cancer cells [27]. Consistently,
IR signiﬁcantly increased the number of puncta-positive cells in
mock (non-transfected) and NC transfected MCF7 cells (⁄⁄P < 0.01).
Importantly, upon ectopic overexpression of miR-199a-5p, only a
limited number of irradiated MCF7 cells were able to form auto-
phagosomes (Fig. 1C, ⁄⁄P < 0.01). Next, we examined the expression
of LC3-II protein by Western blot analysis and found that IR en-
hanced LC3-II protein level which was suppressed upon ectopic
overexpression of miR-199a-5p (Fig. 1D). Both inhibition of auto-
phagosome formation and excessive autophagosomes degradation
can result in reduction of LC3-II [28,26]. To distinguish between
these two possibilities, we used chloroquine (CQ) [26], an agent that
impairs lysosomal acidiﬁcation, to inhibit LC3-II degradation and
thereby detect the autophagic ﬂux [28]. As shown in (Fig. 1E),
miR-199a-5p inhibited IR-induced autophagy as represented by de-
creased LC3-II/I conversion ratio. After IR exposure, LC3-II accumu-
lation was markedly increased in CQ-treated NC transfected cells
(Fig. 1E), whereas it was only minimally altered in miR-199a-5p
transfected cells, indicating the diminished conversion of LC3-I to
LC3-II. These data support that the decrease of LC3-II by miR-
199a-5p resulted from the inhibition of autophagosome formation
and not from excessive autophagosome degradation. Therefore,
miR-199a-5p is a bona ﬁde inhibitor of IR-induced autophagy in
MCF7 breast cancer cells.miR-199a-5p mimic and NC were transfected into MCF7 cells and qRT-PCR was used
essing GFP-LC3 after the treatment of irradiation, left: sham-irradiation, GFP-LC3
ncta positive cell (induction of autophagy by irradiation). (C) MCF7 cells with stable
M), percentage of total GFP puncta positive cells were quantitated (undergoing IR-
three independent experiments (⁄⁄ P < 0.01). (D) Western blot analysis of MAPLC3
ion, MCF7 cells were treated with CQ (20 lM) for 1 h before exposure to irradiation,
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expression in MCF7 cell line
To explore the underlying mechanism by which miR-199a-5p
inhibited autophagy, we combined the database from three popu-
lar microRNA target prediction programs (miRBase, PicTar and Tar-
getscan), searching for the putative autophagy-related target
genes. As a result, we found that DRAM1 and Beclin1 genes were
good candidates, as they contain the matched nucleotides to the
seed sequence of miR-199a-5p (Fig. 2A and B). DRAM1 has been
demonstrated to promote autophagy [29], while Beclin1 is well
appreciated determinant gene in initiation of autophagy [30]. To
provide experimental evidence supporting that DRAM1 or Beclin1
is a target of miR-199a-5p, we cloned the partial 30UTR of DRAM1
or Beclin1 containing miR-199a-5p-binding sequence to ﬁreﬂy
luciferase reporter vector. We examined the effects of miR-199a-
5p on the luciferase activity at these regions by using miR-199a-
5p mimic. Luciferase reporter assay indicated that miR-199a-5p
signiﬁcantly inhibited (⁄P < 0.05) the luciferase activity in the re-
porter vector containing wild-type 30UTR of DRAM1 or Beclin1,
but not in the mutant 30UTR vectors, demonstrating the speciﬁcity
of miR-199a-5p on DRAM1 and Beclin1 30UTR targeting (Fig. 2C and
D). We also examined the impact of miR-199a-5p on endogenous
DRAM1 or Beclin1 protein levels in MCF7 cells. The results showed
that an ectopic increase in miR-199a-5p expression in MCF7 cells
led to marked reduction in DRAM1 and Beclin1 protein content.
Importantly, exposure of MCF7 cells to IR led to up-regulation of
DRAM1 and Beclin1 protein expression levels. MiR-199a-5p overex-
pression obviously attenuated such IR stimulatory effect on DRAM1Fig. 2. MiR-199a-5p down-regulates DRAM1 and Beclin1 expression in MCF7 cells. (A)
Beclin1. Solid line shows the seed match region. (C) and (D) Luciferase activity analysis o
co-transfection with miRNA in MCF7 cells. The error bars indicate the standard error of t
blot analysis DRAM1 and Beclin1 expression in MCF7 cells after transfection or IR.and Beclin1 expression levels (Figs. S1A and S1B; Fig. 2E and F).
These data suggested that miR-199a-5p suppressed IR-induced
autophagy by directly targeting DRAM1 and Beclin1 in MCF7 cells.
3.3. Overexpression of miR-199a-5p up-regulates autophagy, DRAM1,
and Beclin1 in MDA-MB-231 breast cancer cell line
We next sought to explore the impact of miR-199a-5p overex-
pression on autophagy in another breast cancer cell line, MDA-
MB-231 cells. On contrary to MCF7 and rather surprisingly, we
found that upon overexpression of miR-199a-5p in MDA-MB-231
cells, LC3-II/LC3-I conversion ratio was increased as compared to
NC. Furthermore, miR-199a-5p promoted the IR-induced autoph-
agy in this cell line (Fig. 3A, Fig. S1D). To conﬁrm the results, we
measured the autophagic ﬂux. Pre-treatment of MDA-MB-231 cells
with CQ enhanced LC3-II expression, which was further increased
upon miR-199a-5p overexpression (Fig. 3B). These results indicate
that miR-199a-5p promotes autophagosome formation. Therefore
miR-199a-5p behaves as an autophagy inducer in MDA-MB-231
cell line. Such positive relation between miR-199a-5p and autoph-
agy in MDA-MB-231 cells triggered us to examine the impact of
miR-199a-5p on the expression of its target genes DRAM1 and Be-
clin1 in MDA-MB-231. Surprisingly, we found that ectopic overex-
pression of miR-199a-5p in MDA-MB-231 cells led to drastic
increase in expression level of DRAM1 and Beclin1 proteins as indi-
cated by Western blotting (Fig. 3C). Although exposure of MDA-
MB-231 cells to IR led to increased DRAM1 and Beclin1 protein
expression levels, miR-199a-5p overexpression did not further en-
hance the DRAM1 and Beclin1 expression levels in irradiatedand (B) Sequence alignment between miR-199a-5p and the 30UTR of DRAM1 and
f DRAM1 and Beclin1 30UTR (wild type and mutant constructs) were performed after
he mean (S.E.M.) for three independent experiments (⁄P < 0.05). (E) and (F) Western
Fig. 3. MiR-199a-5p overexpression enhanced autophagy and up-regulated DRAM1 and Beclin1 expression in MDA-MB-231 cells. (A) Western blot analysis of MAPLC3
expression in MDA-MB-231 cells after transfection with miRNA or treated with IR. (B) After transfection, MDA-MB-231 cells were treated with CQ (20 lM) and MAPLC3 was
detected by Western blot. (C) Western blot was used to detect the expression of DRAM1 and Beclin1 in MDA-MB-231 cells following the indicated treatments. (D) and (E)
Luciferase activity analysis of DRAM1 and Beclin1 30UTR (wild type and mutant constructs) was performed after co-transfection with miRNA in MDA-MB-231 cells. The error
bars indicate the standard error of the mean (S.E.M.) for three independent experiments (⁄⁄P < 0.01, ⁄P < 0.05).
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underlying mechanism, we co-transfected plasmids carrying
DRAM1 or Beclin1 30UTRs containing the binding site for miR-
199a-5p. Luciferase activity with DRAM1 30UTR and Beclin1 30UTR
constructs increased signiﬁcantly in the miR-199a-5p mimic
MDA-MB-231 transfected cells (⁄P < 0.05, ⁄⁄P < 0.01), and mutation
in the miR-199a-5p target genes sequence led to complete abroga-
tion of the stimulatory effect (Fig. 3D and E). These data suggest
that miR-199a-5p up-regulates DRAM1 and Beclin1 expression di-
rectly through targeting 30UTR of DRAM1 and Beclin1mRNA to pro-
mote basal and IR-induced autophagy in MDA-MB-231 cells.
3.4. MiR-199a-5p regulates IR-induced cell cycle checkpoint
Since it has been suggested by Vasudevan et al. [31] that miR-
NAs could repress their target genes in proliferating cells and acti-
vate their target genes in arrested cells, we sought to explore
whether miR-199a-5p could affect the cell cycle dynamics in both
cell lines. As shown in (Fig. 4A), overexpression of miR-199a-5p in-
duced accumulation of cells at G2/M phase in MDA-MB-231 cell
line, but not in MCF7 cells. Exposure to IR led to decreased propor-
tion of cells at G0/G1 peak and increased proportion of cells at G2/
M peak in both cell lines. Strikingly, we found that IR-induced cell
cycle arrest in MDA-MB-231 and MCF7 cells was abolished by miR-
199a-5p overexpression as analyzed by the ﬂow cytometry assay.
These results indicate that miR-199a-5p overexpression induces
changes in cell proportions pre-IR in MDA-MB-231 cell line and
impairs IR-induced cell cycle arrest in MDA-MB-231 and MCF7 cell
lines.3.5. MiR-199a-5p altered the radiation responsiveness of breast cancer
cells
Since we found that miR-199a-5p could abolish the IR-induced
cell cycle changes, we hypothesized that modulation of miR-199a-
5p could alter the radiosensitivity of the breast cancer cell lines.
First we investigated whether IR could have an impact on miR-
199a-5p expression proﬁle. Using quantitative qRT-PCR, we found
that endogenous miR-199a-5p expression was enhanced by IR in
MCF7 cells but was decreased in MDA-MB-231. After transfection
with mimic, miR-199a-5p expression was up-regulated and further
enhanced by IR in both cell lines (Fig. 4B and C). To determine if
miR-199a-5p mimic could modulate the radiation sensitivity of
breast cancer cells, we performed cell viability assay. In MDA-
MB-231 cell line, we found that miR-199a-5p mimic radiated
group had signiﬁcantly decreased cell viability compared to NC
radiated group (Fig4D). In MCF7 cell line, miR-199a-5p overexpres-
sion did not affect the radiosensitivity signiﬁcantly (data not
shown). These results are consistent with the hypothesis that
miR-199a-5p overexpression induces radiation sensitivity of breast
cancer cells.
4. Discussion
The rapid advancement in our understanding of the mecha-
nisms and regulation of autophagy has placed this process at the
center of current research in major human disorders especially
cancer. Despite that, a huge gap in molecular control of autophagy
still exists [1,32,33]. The novel endogenous gene regulators,
Fig. 4. miR-199a-5p overexpression enhanced the radiosensitivity of MDA-MB-231 cells. (A) Flow cytometry analysis depicted cell-cycle progression of MCF7 and MDA-MB-
231 cells after overexpression of miR-199a-5p or exposure to IR. (B) and (C) qRT-PCR was used to measure the relative expression level of miR-199a-5p after transfection with
mimic and NC or exposure to IR. (D) CCK8 assay was implemented to measure the cell viability in MDA-MB-231 cells after the indicated treatment. The error bars indicate the
standard error of the mean (S.E.M.) for three independent experiments (⁄⁄P < 0.01).
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including growth, development, apoptosis and cancer. Modulation
of autophagy through miRNAs is a novel area of research and still
in its infancy. Several miRNAs have been demonstrated to control
autophagy process via targeting the autophagy related genes in di-
verse human cancer cells [16,17,34,35], These studies helped to
understand autophagy signaling in depth and also offered novel
therapeutic perspectives. Ectopic overexpression of miR-30a in
chronic myelogenous leukemia (CML) cells abrogated the Imati-
nib-induced autophagy via suppression of two target genes Beclin1
and ATG5 to ultimately enhance the cytotoxic effect of imatinib-in-
duced apoptosis [36]. Interestingly, autophagy has been reported
to control miRNA biogenesis and activity, suggesting a feedback
loop between miRNAs and autophagy [37]. In our study, we found
that miR-199a-5p overexpression led to suppression of IR-induced
autophagy in MCF7 breast cancer cell line. However, probably due
to low basal autophagic activity in MCF7, we could not notice an
obvious decrease in percentage of puncta positive cells nor inLC3-II by overexpressing miR-199a-5p pre-IR. Using in silico anal-
ysis, we found DRAM1 and Beclin1 were possible targets of miR-
199a-5p. Recently, studies have shown that DRAM1 belongs to an
evolutionarily conserved family of proteins, and encodes a series
of p53-inducible splice variants, part of which localize to peroxi-
somes and autophagosomes and are required for p53-induced
autophagy [29,38–41]. The other putative target gene, Beclin1/
ATG6 is the widely studied autophagy related gene. Beclin1
has a central role in autophagy machinery and play as a key
autophagy-promoting gene, including IR-induced autophagy
[16,27,42,43]. Using luciferase assay and Western blotting, we
showed that both DRAM1 and Beclin1 are novel target genes for
miR-199a-5p. Overexpression of miR-199a-5p in MCF7 cells sup-
pressed the expression of DRAM1 and Beclin1 via targeting the
30UTR of these genes. Added to this, miR-199a-5p could success-
fully suppress the expression of DRAM1 and Beclin1 proteins in
MCF7 cells in the presence or absence of IR. Collectively, these ﬁnd-
ing imply that miR-199a-5p potently suppresses IR-induced
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Beclin1 at least partially, since a single miRNA could target several
genes simultaneously. Very recently, it has been reported that
miR-199a-5p targets and inhibits autophagy-associated gene 7
(ATG7) to suppress Cisplatin-induced autophagy in liver cancer cells
[44]. In MDA-MB-231, which is characterized by being highly inva-
sive estrogen-receptor negative breast cancer cell line, while MCF7
are non-invasive estrogen-receptor negative cells [45], we showed
that miR-199a-5p behaved in a totally opposite trend. Overexpres-
sionofmiR-199a-5penhancedbothbasal and IR-inducedautophagy
in this cell line. Similarly, miR-199a-5p ectopic overexpression re-
sulted in sharp up-regulation of DRAM1 and Beclin1 target genes
expression through directly targeting 30UTR of DRAM1 or Beclin1
mRNA in MDA-MB-231 cells. From the enormous body of literature
in the ﬁeld of miRNAs, we found only countable number of studies
reported thatmiRNAs could, throughdifferentmechanisms, up-reg-
ulate rather than suppress gene expression. In human liver cells,
miR-122 was found to bind to 50UTR of hepatitis C virus RNA and
activate its translation [46].MiR-10awas found tobind to50UTRseg-
ment of ribosomal protein mRNA, leading to stimulation of ribo-
somal protein mRNA translation and ribosome biogenesis and
ultimately up-regulate global protein synthesis [47]. We excluded
this possiblemechanismby blastingmiR-199a-5p and the 50UTR se-
quence ofDRAM1 and Beclin1, andwe found therewere no potential
binding sites. The other mechanism involved interaction between
thepromoter regionof the geneand speciﬁcmiRNA [48].Wealso ex-
cluded this possible mechanism by blasting miR-199a-5p and the
promoter sequence of DRAM1 and Beclin1, and we found there were
no potential binding sites. Steitz and Vasudevan performed a series
of studies to demonstrate the ability of miRNAs to activate gene
translation by targeting the 30UTR. The authors demonstrated that
cell cycle cues determinewhethermiRNAs activate or repress target
genes. They suggested that miRNAs could activate gene translation
in quiescent phase (cells arrested at G0/G1 phase of cell cycle),
whichwas brought about by serum starvation or contact inhibition,
and repress translation in the later stages of the cell cycle [49–52].
Such phenomenon has been found to occur naturally in Xenopus lae-
vis oocytes [53]. From this perspective, we sought to explore
whether miR-199a-5p induces G0/G1 arrest in order to up-regulate
its target genes. However, we found that miR-199a-5p induced
accumulation of cells at G2/M peak in MDA-MB-231 but not in
MCF7 cell line. After exposing both cell lines to IR, proportion of cells
increased at G2/M and decreased at G0/G1, such event was com-
pletely reversed upon overexpression of miR-199a-5p in both cell
lines. The forthpossibility argues thatmiRNA-mediated gene activa-
tion could be cell-line speciﬁc feature. InMIAPaCa-2pancreatic can-
cer cells, MiR-21 ectopic overexpression led to signiﬁcant up-
regulation of Bcl-2 target gene expression by targeting the 30UTR
of Bcl-2 mRNA, while it was documented that miR-21 suppresses
Bcl-2 expression in breast cancer cells also via targeting Bcl-2 30UTR
[54,55]. Similarly, via direct action on 30UTR of Krüppel-like factor 4
(KLF4) mRNA, overexpression of miR-206 promoted KLF4 gene
expression in MCF10A mammary epithelial cells, while it sup-
pressed expression of KLF4 in MDA-MB-231 breast cancer cells
[56]. Collectively, it seems that the impact of miR-199a-5p on
DRAM1 and Beclin1 genes could be also cell line speciﬁc. Of course,
further comprehensive investigations are warranted. Overall our
ﬁndings add more interest and challenge to further understand
the mechanisms of miRNAs, especially regarding how miRNAs reg-
ulate the gene expression which is still largely illusive [57]. Next
we showed that IR up-regulated miR-199a-5p expression in MCF7
anddown-regulatedmiR-199a-5pexpression inMDA-MB-231cells.
After transfection with mimic, miR-199a-5p expression was en-
hancedpre-IR and further enhanced post-IR inMCF7 cells. However,
we did not observe a decrease of miR-199a-5p inMDA-MD-231 cell
line in response to IR probably due to very high levels of miR-199a-5p after transfection with mimic, similar to [58]. The underlying
mechanismofmiR-199a-5p radio-response could involve ATMactiva-
tionwhichphosphorylatesKSRP (KH-type splicing regulatoryprotein),
the key component in both Drosha and Dicer miRNA-processing com-
plexes, to ultimately enhancemiR-199a and other miRNAs biogenesis
[59]. Finally, using cell viability assay, we showed that miR-199a-5p
overexpression enhanced the radiosensitivity of MDA-MB-231 cell
line. Several studies have demonstrated the signiﬁcance of miRNA
modulation to improve the radio-or chemotherapy,holdingpromising
hope to improve the anti-tumor efﬁcacy [60–63]. However, there is a
big gap in understanding the detailed mechanisms and intracellular
pathways through which miRNAs exert their effects. Thus, further
extensive basic research will be needed to fully lay open the whole
number of miRNAs involved in modulation of chemo- or radiother-
apies and the way they affect cellular homeostasis. Moreover, it is
important to validate the safety and efﬁciency of such treatment
combinations in clinical settings [64].
Brieﬂy, we reported for the ﬁrst time that miR-199a-5p is a no-
vel regulator of basal and IR-induced autophagy in human breast
cancer cells. Moreover, we found that both DRAM1 and Beclin1
are novel target genes, through which miR-199a-5p could probably
regulate autophagy. Uniquely, we demonstrated dual differential
roles of miR-199a-5p in autophagy and target gene expression in
two different human breast cancer cell lines. Collectively, our ﬁnd-
ings provide evidence for a new role of miR-199a-5p in a cellular
process that play signiﬁcant part in carcinogenesis and cancer ther-
apy, which will ultimately assist in better understanding of miR-
NA-modulated autophagic signaling networks and thereby
improve the current and future cancer therapeutic strategies.
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